X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14) 14
male (12) 12
female (11) 11
middle aged (11) 11
adult (7) 7
index medicus (7) 7
risk factors (7) 7
aged (6) 6
thrombosis (6) 6
article (5) 5
prospective studies (5) 5
antiphospholipid antibodies (4) 4
cohort studies (4) 4
diagnosis (4) 4
thromboembolism (4) 4
vein thrombosis (4) 4
venous thrombosis (4) 4
double-blind method (3) 3
hematology (3) 3
odds ratio (3) 3
peripheral vascular disease (3) 3
prevention (3) 3
research (3) 3
risk (3) 3
systemic-lupus-erythematosus (3) 3
thromboembolism - blood (3) 3
abridged index medicus (2) 2
activated protein c resistance (2) 2
activated protein-c (2) 2
aged, 80 and over (2) 2
antibodies, anticardiolipin - blood (2) 2
antibodies, antiphospholipid - blood (2) 2
antibodies, antiphospholipid - immunology (2) 2
antiphospholipid syndrome (2) 2
beta 2-glycoprotein i (2) 2
blood coagulation, fibrinolysis and cellular haemostasis (2) 2
canada - epidemiology (2) 2
cross-sectional studies (2) 2
deep venous thrombosis (2) 2
determinants (2) 2
drug therapy (2) 2
embolisms (2) 2
factor-v-leiden (2) 2
fibrin fibrinogen degradation products - metabolism (2) 2
heparin - administration & dosage (2) 2
immune system diseases (2) 2
ischemic-stroke (2) 2
molecular-weight heparin (2) 2
mutation (2) 2
myocardial-infarction (2) 2
neoplasms (2) 2
original (2) 2
outpatients (2) 2
pulmonary embolism (2) 2
pulmonary embolism - diagnosis (2) 2
recurrence (2) 2
research design (2) 2
rheumatology (2) 2
risk assessment (2) 2
stockings, compression (2) 2
surgery (2) 2
thromboembolism - etiology (2) 2
thromboembolism - prevention & control (2) 2
time factors (2) 2
treatment outcome (2) 2
united states - epidemiology (2) 2
vascular diseases - immunology (2) 2
venous thromboembolism (2) 2
venous thrombosis - blood (2) 2
abdominal surgery (1) 1
accuracy (1) 1
activated clotting time (1) 1
activated protein c resistance - blood (1) 1
activated protein c resistance - immunology (1) 1
acute myeloid leukemia (1) 1
acute nonlymphocytic leukemia (1) 1
acute-phase (1) 1
administration pegfilgrastim (1) 1
adolescent (1) 1
alisertib (1) 1
analgesia (1) 1
anesthesia, epidural (1) 1
anesthetics (1) 1
angiography (1) 1
angiography - trends (1) 1
anti-beta2-glycoprotein i (1) 1
anti-cardiolipin antibody (1) 1
antibodies (1) 1
antibodies, anticardiolipin - immunology (1) 1
antibodies, anticardiolipin - metabolism (1) 1
antibodies, antiphospholipid - metabolism (1) 1
anticadiolipin antibody (1) 1
anticardiolipin (1) 1
anticardiolipin antibodies (1) 1
anticardiolipin antibody (1) 1
anticoagulant (1) 1
anticoagulant activity (1) 1
anticoagulants (1) 1
anticoagulants - administration & dosage (1) 1
anticoagulants - adverse effects (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2014, Volume 383, Issue 9920, pp. 880 - 888
Journal Article
Journal of Vascular Surgery: Venous and Lymphatic Disorders, ISSN 2213-333X, 2015, Volume 3, Issue 4, pp. 347 - 353.e1
Objective Inflammation may play a role in pathogenesis of venous thromboembolism, but the nature of this relationship is not yet understood. The objective of... 
Surgery | C-REACTIVE PROTEIN | SURGERY | VEIN THROMBOSIS | ACUTE-PHASE | DETERMINANTS | RISK | PERIPHERAL VASCULAR DISEASE | THROMBOEMBOLISM | POSTTHROMBOTIC SYNDROME | Postthrombotic Syndrome - diagnosis | Venous Thrombosis - diagnosis | C-Reactive Protein | Humans | Middle Aged | Risk Factors | Biomarkers | Male | Stockings, Compression - adverse effects | Inflammation | Thrombosis | Interleukin-6
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2017, Volume 12, Issue 1, p. e0169268
Journal Article
Leukemia Research Reports, ISSN 2213-0489, 2014, Volume 3, Issue 2, pp. 58 - 61
Abstract Alisertib (MLN8237) is an investigational, oral, selective, Aurora A kinase (AAK) inhibitor. In this phase 2 trial, 57 patients with acute myeloid... 
Hematology, Oncology and Palliative Medicine | Pathology | Myelodysplastic syndrome (MDS) | Safety | Alisertib | Aurora A kinase inhibitor | Acute myeloid leukemia (AML)
Journal Article
BMC Cancer, ISSN 1471-2407, 07/2008, Volume 8, Issue 1, pp. 195 - 195
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 07/2003, Volume 90, Issue 1, pp. 108 - 115
Journal Article
Journal Article
Clinical Cardiology, ISSN 0160-9289, 05/2018, Volume 41, Issue 5, pp. 576 - 585
Journal Article
Journal Article
American Journal of Nephrology, ISSN 0250-8095, 01/2002, Volume 22, Issue 1, p. 58
  Low-molecular-weight heparins offer several advantages over standard heparins, but their use for maintenance hemodialysis has been limited in North America... 
Journal Article
Journal Article